netFormulary
 Report : A-Z NHS England items in Formulary 03/06/2020 17:08:19
[Back]
 
Section Status NHS England Name
03.04.02 Formulary MHS England Omalizumab Xolair®
10.01.03 Formulary MHS England Abatacept Orencia®
08.01.05 Formulary MHS England Abemaciclib Verzenios®
08.03.04.02 Formulary MHS England Abiraterone acetate Zytiga®
10.01.03 Formulary MHS England Adalimumab Hyrimoz®, Amgevita®, Imraldi®, Hulio®, Humira®
11.04.01 Formulary MHS England Adalimumab  Hyrimoz®, Amgevita®, Imraldi®, Hulio®, Humira®
13.05.03 Formulary MHS England Adalimumab Hyrimoz®, Amgevita®, Imraldi®, Hulio®, Humira®
13.06 Formulary MHS England Adalimumab Hyrimoz®, Amgevita®, Imraldi®, Hulio®, Humira®
05.03.03.01 Formulary MHS England Adefovir Dipivoxil Hepsera®
08.01.05 Formulary MHS England Afatinib dimaleate Giotrif®
08.02.03 Formulary MHS England Alemtuzumab Lemtrada®
02.05.01 Formulary MHS England Ambrisentan Volibris®
10.02.01 Formulary MHS England Amifampridine Firdapse®
10.01.03 Formulary MHS England Anakinra Kineret®
10.01.03 Formulary MHS England Apremilast Otezla®
08.02.04 Formulary MHS England Axicabtagene ciloleucel Yescarta®
08.01.05 Formulary MHS England Axitinib Inlyta®
08.01.03 Formulary MHS England Azacitidine Vidaza®
08.02.01 Formulary MHS England Azathioprine 
05.01.02.03 Formulary MHS England Aztreonam lysine powder nebuliser solution Cayston®
08.02.02 Formulary MHS England Basiliximab Simulect®
10.01.03 Formulary MHS England Belimumab Benlysta®
08.01.01 Formulary MHS England Bendamustine hydrochloride 
03.04.02 Formulary MHS England Benralizumab Fasenra®
03.05.02 Formulary MHS England Beractant Survanta®
08.02.03 Formulary MHS England Blinatumomab Blincyto®
05.03.03.02 Formulary MHS England Boceprevir Victrelis®
08.01.05 Formulary MHS England Bortezomib Velcade®
08.01.05 Formulary MHS England Bosutinib Bosulif®
08.01.05 Formulary MHS England Brentuximab vedotin Adcetris®
08.01.05 Formulary MHS England Brigatinib Alunbrig®
03.04.03 Formulary MHS England C1 esterase inhibitor 
08.01.05 Formulary MHS England Cabazitaxel Jevtana®
08.01.05 Formulary MHS England Cabozantinib Cabometyx®
04.08.01 Formulary MHS England Cannabidiol Epidyolex®
08.01.05 Formulary MHS England Carfilzomib Kyprolis®
08.01.05 Formulary MHS England Cemiplimab Libtayo®
08.01.05 Formulary MHS England Ceritinib Zykadia®
10.01.03 Formulary MHS England Certolizumab Pegol Cimzia®
08.01.05 Formulary MHS England Cetuximab Erbitux®
08.02.02 Formulary MHS England Ciclosporin Cyclosporin
09.05.01.02 Formulary MHS England Cinacalcet hydrochloride Mimpara®
08.01.03 Formulary MHS England Cladribine Mavenclad ®
05.01.07 Formulary MHS England Colistimethate dry powder for nebuliser Colobreathe®
03.04.03 Formulary MHS England Conestat Alfa Ruconest®
08.01.05 Formulary MHS England Crizotinib Xalkori®
08.01.03 Formulary MHS England Cytarabine–daunorubicin liposomal  Vyxeos®
08.01.05 Formulary MHS England Dabrafenib mesilate Tafinlar®
05.03.03.02 Formulary MHS England Daclatasvir  Daklinza®
08.01.05 Formulary MHS England Dacomitinib Vizimpro®
08.01.05 Formulary MHS England Daratumumab Darzalex®
09.01.03 Formulary MHS England Darbepoetin Alfa Aranesp®
05.03.03.02 Formulary MHS England Dasabuvir Sodium Monohydrate Exviera®
08.01.05 Formulary MHS England Dasatinib Sprycel®
06.06.02 Formulary MHS England Denosumab 
08.02.04 Formulary MHS England Dimethyl fumarate Tecfidera®
03.07 Formulary MHS England Dornase Alfa Pulmozyme®
08.01.05 Formulary MHS England Doxorubicin hydrochloride Caelyx®
08.01.05 Formulary MHS England Durvalumab Imfinzi®
09.01.03 Formulary MHS England Eculizumab Soliris®
05.03.03.02 Formulary MHS England Elbasvir & Grazoprevir Zepatier®
09.08.01 Formulary MHS England Elosulfase alfa Vimizim®
08.01.05 Formulary MHS England Encorafenib  Braftovi®
05.03.03.01 Formulary MHS England Entecavir Monohydrate Baraclude®
08.03.04.02 Formulary MHS England Enzalutamide Xtandi®
09.01.03 Formulary MHS England Epoetin Alfa  Eprex®
09.01.03 Formulary MHS England Epoetin Beta NeoRecormon®
09.01.03 Formulary MHS England Epoetin Zeta Retacrit®
02.08.01 Formulary MHS England Epoprostenol Flolan®
08.01.05 Formulary MHS England Eribulin Halaven®
08.01.05 Formulary MHS England Erlotinib hydrochloride Tarceva®
10.01.03 Formulary MHS England Etanercept Enbrel®, Benepali®, Erelzi®
09.05.01.02 Formulary MHS England Etelcalcetide hydrochloride Parsabiv®
08.01.05 Formulary MHS England Everolimus 
10.02.01 Formulary MHS England Fampridine Fampyra®
08.02.04 Formulary MHS England Fingolimod Gilenya®
08.01.05 Formulary MHS England Gefitinib Iressa®
08.01.05 Formulary MHS England Gemtuzumab ozogamicin Mylotarg®
08.02.04 Formulary MHS England Glatiramer acetate Copaxone®
05.03.03.02 Formulary MHS England Glecaprevir & Pibrentasvir Maviret®
10.01.03 Formulary MHS England Golimumab Simponi®
03.04.03 Formulary MHS England Icatibant Firazyr®
08.01.05 Formulary MHS England Idelalisib Zydelig®
08.01.05 Formulary MHS England Imatinib mesilate 
10.01.03 Formulary MHS England Infliximab Flixabi®, Inflectra®, Remicade®, Remsima®
08.02.04 Formulary MHS England Interferon Alfa 
08.02.04 Formulary MHS England Interferon Beta 
08.01.05 Formulary MHS England Ipilimumab Yervoy®
03.07 Formulary MHS England Ivacaftor Kalydeco®
08.01.05 Formulary MHS England Ixazomib Ninlaro®
03.04.03 Formulary MHS England Lanadelumab Takhzyro®
08.03.04.03 Formulary MHS England Lanreotide acetate 
09.05.02.02 Formulary MHS England Lanthanum carbonate Fosrenol®
05.03.03.02 Formulary MHS England Ledipasvir & Sofosbuvir Harvoni®
08.02.04 Formulary MHS England Lenalidomide Revlimid®
09.01.06 Formulary MHS England Lenograstim Granocyte®
08.01.05 Formulary MHS England Lenvatinib 
05.03.02.02 Formulary MHS England Letermovir Prevymis®
05.01.12 Formulary MHS England Levofloxacin nebuliser solution Quinsair®
03.07 Formulary MHS England Mannitol inhalation Bronchitol ®
02.03.02 Restricted Use MHS England Mexiletine Mexitil®, Namuscla®
08.02.01 Formulary MHS England Mycophenolate Mofetil 
08.02.04 Formulary MHS England Natalizumab Tysabri®
08.03.04.01 Formulary MHS England Neratinib Nerlynx®
08.01.05 Formulary MHS England Nilotinib Tasigna®
08.01.05 Formulary MHS England Nintedanib esilate 
08.01.05 Formulary MHS England Nivolumab Opdivo®
10.02 Formulary MHS England Nusinersen Spinraza ®
08.01.05 Formulary MHS England Obinutuzumab Gazyvaro®
08.02.03 Formulary MHS England Obinutuzumab Gazyvaro®
08.02.03 Formulary MHS England Ocrelizumab Ocrevus®
08.03.04.03 Formulary MHS England Octreotide acetate 
08.02.03 Formulary MHS England Ofatumumab Arzerra®
08.01.05 Formulary MHS England Olaparib Lynparza®
08.01.05 Formulary MHS England Olaratumab Lartruvo®
05.03.03.02 Formulary MHS England Ombitasvir, paritaprevir & ritonavir Viekirax®
08.01.05 Formulary MHS England Osimertinib Tagrisso®
08.01.05 Formulary MHS England Paclitaxel 
08.01.05 Formulary MHS England Palbociclib Ibrance®
08.01.05 Formulary MHS England Panitumumab Vectibix®
08.01.05 Formulary MHS England Panobinostat Farydak®
08.01.05 Formulary MHS England Pazopanib Votrient®
08.01.05 Formulary MHS England Pegaspargase Oncaspar®
08.02.04 Formulary MHS England Peginterferon Alfa Pegasys®
08.02.04 Formulary MHS England Peginterferon Beta-1a Plegridy®
08.01.05 Formulary MHS England Pembrolizumab Keytruda®
08.01.05 Formulary MHS England Pertuzumab Perjeta®
03.11 Formulary MHS England Pirfenidone Esbriet®
08.01.02 Formulary MHS England Pixantrone dimaleate Pixuvri®
09.01.07 Formulary MHS England Plerixafor Mozobil®
08.02.04 Formulary MHS England Pomalidomide Imnovid®
08.01.05 Formulary MHS England Ponatinib Iclusig®
03.05.02 Formulary MHS England Poractant Alfa Curosurf®
08.01.05 Formulary MHS England Regorafenib Stivarga®
03.04.02 Formulary MHS England Reslizumab Cinquil®
05.03.03.02 Formulary MHS England Ribavirin 
08.01.05 Formulary MHS England Ribociclib succinate Kisqali®
08.02.03 Formulary MHS England Rituximab MabThera®, Rixathon®, Truxima®
10.01.03 Formulary MHS England Rituximab MabThera®, Rixathon®, Truxima®
08.02.04 Formulary MHS England Rucaparib Rubraca®
08.01.05 Formulary MHS England Ruxolitinib phosphate Jakavi®
10.01.03 Formulary MHS England Secukinumab Cosentyx®
09.05.02.02 Formulary MHS England Sevelamer  
05.03.03.02 Formulary MHS England Simeprevir Olysio®
05.03.03.02 Formulary MHS England Sofosbuvir Sovaldi®
05.03.03.02 Formulary MHS England Sofosbuvir & Velpatasvir Epclusa®
05.03.03.02 Formulary MHS England Sofosbuvir, velpatasvir & voxilaprevir Vosevi®
08.01.05 Formulary MHS England Sorafenib tosylate Nexavar®
08.01.05 Formulary MHS England Sunitinib Sutent®
08.02.02 Formulary MHS England Tacrolimus 
08.01.05 Formulary MHS England Talimogene laherparepvac Imlygic®
05.03.03.02 Formulary MHS England Telaprevir Incivo®
05.03.03.01 Formulary MHS England Tenofovir Disproxil Viread®
05.03.01 Formulary MHS England Tenofovir, cobicistat, elvitegravir & emtricitabine Stribild®
08.02.04 Formulary MHS England Teriflunomide Aubagio®
08.02.04 Formulary MHS England Thalidomide Celgene®
08.01.05 Formulary MHS England Tisagenlecleucel Kymriah®
08.01.05 Formulary MHS England Tivozanib Fotivda®
05.01.04 Formulary MHS England Tobramycin dry powder for inhalation Tobi® Podhaler
10.01.03 Formulary MHS England Tocilizumab RoActemra®
06.05.02 Formulary MHS England Tolvaptan Jinarc®
08.01.05 Formulary MHS England Trabectedin Yondelis®
08.01.05 Formulary MHS England Trametinib Mekinist®
08.01.05 Formulary MHS England Trastuzumab 
08.01.05 Formulary MHS England Trifluridine-tipiracil Lonsurf®
08.01.05 Formulary MHS England Vemurafenib Zelboraf®
08.01.05 Formulary MHS England Venetoclax Venclyxto®
North Staffordshire Joint Formulary